Promising
Metformin
The prediction game
Call it: rising or fading?
Where does Metformin stand 12 months from now? Lock your call with a confidence level. When the window closes, the Brier rule scores your calibration: right and confident earns the most, wrong and confident costs the most. Points and a leaderboard spot are the whole prize. No stakes, no money.
One call per intervention. It locks the moment you submit: no edits, no cancels. It resolves when the 12-month window closes.
The Crowd’s Call
Rising or fading over the next 12 months? Lock your call and find out if you saw it coming.
Community Signal
No weigh-ins yet. Be the first and set the early signal.
Evidence
Evidence grade: A (strong evidence)
Graded from the strength of the published research, independent of any verdict on this page.
Evidence Anchor
BioHarmony 6.9/10
Metformin offers clinically proven glucose lowering for overweight adults with type 2 diabetes and can modestly lower the risk of progressing from prediabetes to diabetes, making it a reasonable first-line option for those who need affordable, prescription-grade metabolic support. The evidence supports a 30-plus percent reduction in diabetes incidence in high-risk individuals [Knowler et al. 2002](https://pubmed.ncbi.nlm.nih.gov/11832527/) and a 30-plus percent drop in all-cause mortality among newly diagnosed overweight patients [UK Prospective Diabetes Study Group 1998](https://pubmed.ncbi.nlm.nih.gov/9742977/). Benefits extend to modest weight loss, improved insulin sensitivity, and a potential longevity signal in observational cohorts, although these signals remain preliminary. Safety concerns focus on gastrointestinal upset, vitamin B12 depletion, and rare lactic acidosis in renal impairment, so regular monitoring is advised. Users seeking hormonal or fertility benefits should note that modest improvements have been observed in polycystic ovary syndrome, but the effect size is modest. ✅ Best for: Adults with type 2 diabetes who need low-cost foundational glucose control and can monitor kidney function and B12. Prediabetes case-by-case when BMI >=30, fasting glucose is high, age is under 60, or prior gestational diabetes raises risk, especially after lifestyle-first work. Insulin-resistant PCOS where ovulation, androgen, and metabolic endpoints matter. Metabolically unhealthy adults where modest weight, glucose, and cardiometabolic risk reduction justify a prescription drug. Longevity-curious users should wait for TAME or use clinician-guided, non-daily, context-specific dosing rather than assuming chronic use is upside-only. ❌ Avoid if: eGFR is below 30; you have acute kidney injury, sepsis, severe dehydration, severe liver disease, active alcohol abuse, decompensated heart failure, hypoxic illness, or an upcoming iodinated contrast procedure that meets FDA hold criteria. Avoid casual daily use if you are a healthy athlete training for hypertrophy, strength, or VO2max, because Konopka 2019 and Walton 2019 show adaptation tradeoffs. Also avoid treating metformin as proven cancer prevention, long-COVID treatment, osteoarthritis therapy, AMD prevention, or healthy-adult anti-aging medicine.
Read the full BioHarmony report
My score and my verdict: one signal of three, never the whole answer.
Momentum
Signals begin with Edition 2
Direction needs two weekly snapshots to compare, so the arrows stay off until the next edition. Attention tracking is already running.
In the news this week: Hunter Williams, Jay Campbell.
Momentum = how fast attention is rising across search, Reddit, PubMed, podcasts, and curated industry newsletters this week; it can flag an item as Overhyped/Fading, but it never overrides the evidence behind Proven. How momentum works.
- Ring
- Promising
- Trend
- Begins with Edition 2
- Momentum
- 10.9%
- BioHarmony Score
- 6.9/10
- Last Updated
- Jul 2, 2026
Sources
- BioHarmony score
- Search trend delta
- Reddit velocity
- PubMed publication count
- Podcast mention frequency
- Curated newsletter mentions
The score anchors the ring; the other five drive momentum, which can nudge the ring by one step at most. How placement works.
Weigh In
Your input feeds the community signal shown beside my verdict. It informs the board and it never sets the score by itself. How community input works.
New voice here? We send a one-tap verification link so every entry comes from a real person. Signed-in members skip this.